Key result
Oral contraceptives are not significantly linked to atherothrombotic outcomes in women under 55 after STEMI PCI.
Why the study?
The presentation and clinical course of acute myocardial infarction in women using oral contraceptives in Brazil had not been described.
Does oral contraceptive use affect the clinical characteristics, procedural aspects, and outcomes of women aged < 55 years undergoing primary PCI for STEMI?
Cohort (n=257)
Does oral contraceptive use affect the clinical characteristics, procedural aspects, and outcomes of women aged < 55 years undergoing primary PCI for STEMI?
Young women with STEMI using oral contraceptives present with distinct clinical and procedural characteristics, including higher rates of thrombus aspiration, but may have favorable long-term atherothrombotic outcomes compared to non-users.
Answers are grounded in this paper and cite their sources.
Should not change practice; leaves open a possible protective association of oral contraceptive use in young women post-STEMI PCI.
Background In Brazil, it is estimated that approximately 27% of women of childbearing age use oral contraceptives (OC). The presentation and clinical course of acute myocardial infarction (AMI) in these women has yet to be described in Brazil. The aim of this study was to analyze the clinical profile, angiographic characteristics, technical aspects of the procedure, and the outcomes in women using OC who had an AMI and were submitted to primary percutaneous coronary intervention (PCI). Methods Women aged < 55 years who had acute ST segment elevation myocardial infarct and were referred to primary PCI were sequentially included and categorized into two groups: with and without current use of OC. Results We have included 257 patients, of whom 19 (7.4%) used OC. These patients were younger (42.3 ± 6.2 years vs. 48.4 ± 5.7 years; p < 0.001), with fewer traditional risk factors for coronary artery disease, but had higher serum levels of C-reactive protein and fibrinogen. The delta T was similar (4.00 [1.25 to 6.86] hours vs. 4.50 [2.50 to 7.64] hours; p = 0.54), but the door-to-balloon time was longer in patients taking OC (1.41 [0.58 to 1.73] hours vs. 1.16 [0.91 to 1.51] hour, p = 0.02). These patients were more frequently submitted to thrombus aspiration (52.6% vs. 25.6%; p = 0.04). After the index event, they had no atherothrombotic outcomes in up to 2 years of follow-up (0 vs. 15.2%; p = 0.08). Conclusions In this study, different clinical profiles and outcomes were found among women of reproductive age, users or non-users of OC, and submitted to primary PCI. Studies with a larger number of patients are required to confirm these results.
No takes yet. Share an insight, caveat, or question.
Mariano et al. (2015) conducted a cohort in Acute ST segment elevation myocardial infarction (STEMI) (n=257). Oral contraceptive use vs. No current use of oral contraceptives was evaluated on Atherothrombotic outcomes (p=0.08). Among women aged <55 years undergoing primary PCI for STEMI, oral contraceptive use was associated with 0% atherothrombotic outcomes at 2 years compared to 15.2% in non-users (p=0.08).
Synapse has enriched 10 related papers. Consider them for comparative context: